Immunohistochemical analysis of 225 primary HCC tumors demonstrated SETD7 overexpression compared to neighboring non-tumorous counterparts and correlation with adverse clinicopathologic features, such as tumor size and histologic grade [40]. This evidence concerns the gene SETD7 and neoplasm.